£128.47

Recent Approaches For The Treatment Of Alzheimer’s Disease

Price data last checked 44 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£128 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 47 days · 47 data points (no recent data)

Historical
Generating forecast…
£128.47 £122.05 £124.62 £127.19 £129.75 £132.32 £134.89 26 April 2026 07 May 2026 19 May 2026 30 May 2026 11 June 2026

Price Distribution

Price distribution over 47 days • 1 price levels

Days at Price
47 days 0 12 24 35 47 £128 Days at Price

Price Analysis

Most common price: £128 (47 days, 100.0%)

Price range: £128 - £128

Price levels: 1 different prices over 47 days

Description

Today most of the people in the world now have suffered from Alzheimer’s disease. Alzheimer’s destroys brain cells, causing problems with memory, thinking and behavior severe enough to affect work, lifelong hobbies or social life. Alzheimer’s gets worse over time, and it is fatal. Today it is the seventh-leading cause of death in the world. Today one cannot depend on the single drug for the treatment of Alzheimer’s disease. There are many drug therapies for the treatment of AD. Additionally, screening and early diagnosis provides an avenue for trial of the new range of medications with some potential for slowing progression of some dementias. For all of these reasons, screening people reporting loss of memory is a valuable approach to promote. The primary goals of treatment of patients with AD are to improve quality of life and maximize functional performance by enhancing cognition, mood, and behavior. Treatments include pharmacologic and non-pharmacologic approaches. Drugs such as Tacrine, Donepezil, Rivastigmine, selegiline, valproate, memantine, clioquinol and various antioxidants are used to improve the quality of life. Therefore, the pharmaceutical formulations with combination of drugs have shown an increasing trend to counteract other symptoms specific to one drug formulations hence analytical chemist will have to accept the challenges of developing reliable methods for the analysis of drugs in such formulations.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
21 February 2021
Listed Since
22 February 2021

Barcode

No barcode data available

Similar Products You Might Like

Practical Pharmacology for Alzheimer’s Disease
97% match

Practical Pharmacology for Alzheimer’s Disease

Springer

£145.35 14 Jul 2026
Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics
97% match

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics

Springer

£82.10 05 Jul 2026
Practical Pharmacology for Alzheimer’s Disease
97% match

Practical Pharmacology for Alzheimer’s Disease

Springer

£76.63 14 Jul 2026
Multi-Factorial Approach as a Therapeutic Strategy for the Management of Alzheimer’s Disease
96% match

Multi-Factorial Approach as a Therapeutic Strategy for the Management of Alzheimer’s Disease

Springer

Price unavailable
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges
96% match

Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Academic Press

£90.48 03 Jul 2026
Neuroprotection in Alzheimer's Disease
96% match

Neuroprotection in Alzheimer's Disease

Academic Press

£88.59 10 Jul 2026
Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)
96% match

Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)

Humana

£84.81 09 Jul 2026
Pharmacological Mechanisms in Alzheimer's Therapeutics
96% match

Pharmacological Mechanisms in Alzheimer's Therapeutics

Springer

£107.98 11 Jun 2026
The Biology of Alzheimer Disease (Cold Spring Harbor Perspectives in Medicine)
96% match

The Biology of Alzheimer Disease (Cold Spring Harbor Perspectives in Medicine)

Cold Spring Harbor Laboratory Press

£85.00 16 Jun 2026
Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4
96% match

Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4

£11.43 04 Jul 2026
Computational and Experimental Studies in Alzheimer's Disease
96% match

Computational and Experimental Studies in Alzheimer's Disease

CRC Press

£107.98 17 Jun 2026
Alzheimer's Disease and Related Disorders: Etiology, Pathogenesis and Therapeutics
96% match

Alzheimer's Disease and Related Disorders: Etiology, Pathogenesis and Therapeutics

Wiley-Blackwell

£139.28 10 Jun 2026
Ageing and Dementia (Journal of Neural Transmission. Supplementa): 53
96% match

Ageing and Dementia (Journal of Neural Transmission. Supplementa): 53

Springer

£172.84 13 Jun 2026
American Psychiatric Publishing Textbook of Alzheimer Disease and Other Dementias
96% match

American Psychiatric Publishing Textbook of Alzheimer Disease and Other Dementias

American Psychiatric Association Publishing

£95.24 24 Jul 2026
Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)
96% match

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

CRC Press

£87.80 09 Jul 2026
Research Progress in Alzheimer's Disease and Dementia, Volume 2: v. 2
96% match

Research Progress in Alzheimer's Disease and Dementia, Volume 2: v. 2

£69.64 09 Jul 2026
Molecular Mechanisms of Dementia (Contemporary Neuroscience)
96% match

Molecular Mechanisms of Dementia (Contemporary Neuroscience)

Humana

£69.92 13 Jul 2026
The Dementias: Diagnosis, Management, and Research
96% match

The Dementias: Diagnosis, Management, and Research

American Psychiatric Association Publishing

£113.00 18 Jul 2026
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease
96% match

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Academic Press

£92.39 02 Jul 2026
Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)
96% match

Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Humana

£138.79 18 Jun 2026
Psychology Press - Clinical Management of Early Alzheimer's Disease
96% match

Psychology Press - Clinical Management of Early Alzheimer's Disease

Psychology Press

£37.21 17 Jul 2026
Management of Dementia, Second Edition - CRC Press Book
96% match

Management of Dementia, Second Edition - CRC Press Book

CRC Press

£165.00 20 Jul 2026
The End of Alzheimer's: The Brain and Beyond
96% match

The End of Alzheimer's: The Brain and Beyond

Academic Press

£50.59 07 Jul 2026
Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations
96% match

Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations

Wiley

£179.95 27 Jun 2026